Journal of Clinical Medicine Review Ganglionated Plexi Ablation for the Treatment of Atrial Fibrillation 1, 1, 2 2 3,4 Sahar Avazzadeh y , Shauna McBride y, Barry O’Brien , Ken Coffey , Adnan Elahi , Martin O’Halloran 3, Alan Soo 5 and Leo. R Quinlan 1,* 1 Physiology and Human Movement Laboratory, CÚRAM SFI Centre for Research in Medical Devices, School of Medicine, Human biology building, National University of Ireland (NUI) Galway, H91 TK33 Galway, Ireland;
[email protected] (S.A.);
[email protected] (S.M.) 2 AtriAN Medical Limited, Unit 204, NUIG Business Innovation Centre, Upper Newcastle, H91 TK33 Galway, Ireland;
[email protected] (B.O.); ken.coff
[email protected] (K.C.) 3 Translational Medical Devise Lab (TMD Lab), Lambe Institute of Translational Research, University College Hospital Galway, H91 ERW1 Galway, Ireland;
[email protected] (A.E.);
[email protected] (M.O.) 4 Electrical & Electronic Engineering, School of Engineering, National University of Ireland Galway, H91 TK33 Galway, Ireland 5 Department of Cardiothoracic Surgery, University Hospital Galway, Saolta Hospital HealthCare Group, H91 YR71 Galway, Ireland;
[email protected] * Correspondence:
[email protected]; Tel.: +35-3-9149-3710 Joint first author. y Received: 7 August 2020; Accepted: 23 September 2020; Published: 24 September 2020 Abstract: Atrial fibrillation (AF) is the most common type of cardiac arrhythmia and is associated with significant morbidity and mortality. The autonomic nervous system (ANS) plays an important role in the initiation and development of AF, causing alterations in atrial structure and electrophysiological defects. The intrinsic ANS of the heart consists of multiple ganglionated plexi (GP), commonly nestled in epicardial fat pads.